Selected article for: "acute respiratory syndrome and adaptation exercise"
Author: Evangelista, Fabiana S.
Title: Physical Exercise and the Renin Angiotensin System: Prospects in the COVID-19
  • Cord-id: 6iwkoesk
  • Document date: 2020_10_15
    • ID: 6iwkoesk
    Snippet: Recent reports have shown that the renin angiotensin system (RAS) plays an important role in the Coronavirus disease 2019 (COVID-19) because the angiotensin converting enzyme 2 is the receptor for the severe acute respiratory syndrome coronavirus 2. In addition, the balance of RAS components can be involved in the pathogenesis and progression of COVID-19, especially in patients with metabolic and cardiovascular diseases. On the other hand, physical exercise is effective to prevent and to counter
    Document: Recent reports have shown that the renin angiotensin system (RAS) plays an important role in the Coronavirus disease 2019 (COVID-19) because the angiotensin converting enzyme 2 is the receptor for the severe acute respiratory syndrome coronavirus 2. In addition, the balance of RAS components can be involved in the pathogenesis and progression of COVID-19, especially in patients with metabolic and cardiovascular diseases. On the other hand, physical exercise is effective to prevent and to counteract the consequences of such diseases and one of the biological mediators of the exercise adaptation is the RAS. This review was designed to highlight the connection between COVID-19 and RAS, and to discuss the role of the RAS as a mediator of the benefits of physical exercise in COVID-19 pandemic.

    Search related documents:
    Co phrase search for related documents
    • ace activity and acute lung injury: 1, 2, 3, 4, 5, 6, 7, 8
    • ace activity and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • ace angiotensin convert enzyme and acute respiratory syndrome: 1
    • ace homologue enzyme and acute lung injury: 1, 2
    • ace homologue enzyme and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • ace inhibitor and acute lung injury: 1, 2, 3, 4
    • ace inhibitor and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ace inhibitor and adipose tissue: 1
    • ace reduce and acute respiratory syndrome: 1
    • active peptide and acute lung injury: 1
    • active peptide and acute respiratory syndrome: 1, 2, 3, 4
    • active peptide and adipose tissue: 1
    • acute lung injury and adipose tissue: 1, 2
    • acute lung injury and adipose tissue mass: 1
    • acute respiratory syndrome and adipose tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and adipose tissue mass: 1, 2, 3